Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7191 participants
OBSERVATIONAL
2022-04-17
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is funded by Global Fund/Regional Artemisinin Initiative (RAI3E). The grant reference number is QSE-M-UNOPS-MORU-20864-007-42
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Malaria Genetic Surveillance in Cambodia
NCT03384472
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
NCT05117567
Targeted Chemo-elimination (TCE) of Malaria
NCT01872702
Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia)
NCT04041973
Malaria Genetic Surveillance
NCT03384498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For this project, the study team will test specific examples of expanded roles of VMWs including testing for other causes of fever in people who are malaria negative and assessing the feasibility of diagnostics other than malaria RDTs at health centres. Quantitative and qualitative data will be collected to determine acceptability, a mixed-methods approach will be used for the assessment:
• Quantitative method
Participants with febrile illness attending village malaria workers will be tested by novel rapid diagnostic tests (Dengue and CRP rapid test) in addition to a standard malaria test. Village malaria workers (VMWs)/ mobile malaria workers (MMWs) will be trained to conduct a package of activities ((i) hygiene and sanitation; (ii) disease surveillance; (iii) EPI and ANC support; (iv) management of mild common illnesses that they will carry out alongside their usual role of testing (RDTs) and treating malaria. If possible, within a week of conducting a novel RDT, a well-being follow up will be undertaken by the VMW, either via telephone or face-to-face. For the primary outcomes, the study team will report numbers and proportions of training modules passed, malaria tests performed, new diagnostic tests performed correctly, algorithms followed correctly, number of consultations, coverage estimates, and the study team will use the national malaria information system to provide a comparison in activity levels compared to other areas of Cambodia. The study team will record the incidence and aetiology of febrile illnesses.
• Qualitative method
A set of interviews/discussions with health centre staffs and local stakeholders will be conducted to refine the intervention design and implementation strategy. To this end, the interviews will elicit the views and experience of local stakeholders on (1) health care needs and gaps in local communities, (2) views and past experiences concerning the implementation of the VMW programme, with a focus on challenges and good practices around the use of RDTs, and (3) their views about suitable methods and strategies to expand the current VMW programme considering the new technologies available.
Findings from the study will highlight to the wider scientific community the benefits and challenges of expanding the roles of VMW/MMWs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with febrile illness
Febrile patients attending village malaria workers (VMWs)
No interventions assigned to this group
Health centre staffs
Health centre staffs from 12 rural health centres
No interventions assigned to this group
Key stakeholders
Key stakeholders , for example health managers and health professionals:
* the director, deputy-directors, and technical officers at the National Malaria Control Program;
* the directors and deputy-directors of the Provincial Health Departments in Battambang and Pailin province;
* health officers actively involved in community-based (malaria) programmes at the district levels in Battambang and Pailin provinces;
* health workers (i.e., nurses or doctors) actively involved in community-based (malaria) programmes in Battambang and Pailin provinces;
* community representatives and village malaria workers from villages in both Battambang Pailin province.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Willingness to provide blood sample
* Fever (≥37.5 C) or history of fever within 24 hours
2. Qualitative research
2.1 Health centre-based evaluation of novel diagnostics
* Health centre staff who have received training in the use of the novel diagnostics used in the study
* Willing and able to give informed consent for participation in the study
2.2 Stakeholder analysis
* Adults, male or female, aged 18 years and over
* Willing and able to give informed consent for participation in the study
Exclusion Criteria
• Participants requires urgent medical attention
2. Qualitative research
* Identified with intellectual and/or cognitive disability
* History of or current psychiatric illness
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol Oxford Tropical Medicine Research Unit
OTHER
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas J Peto, Dr.
Role: PRINCIPAL_INVESTIGATOR
Mahidol Oxford Tropical Medicine Research Unit
James J Callery, Dr.
Role: PRINCIPAL_INVESTIGATOR
Mahidol Oxford Tropical Medicine Research Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Action for Health and Development
Battambang, , Cambodia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCR21005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.